靜脈注射液市場規模、佔有率、成長分析、按產品、按營養素、按地區 - 產業預測，2024-2031年

2022年全球靜脈注射液市場規模為119.9億美元，從2023年的129.5億美元成長到2031年的239.6億美元，在預測期內（2024-2031年）預計年複合成長率為8.0。

全球靜脈注射液市場呈現穩定成長，主要得益於慢性病增加、家庭醫療服務需求增加、老年人口快速成長。這些無菌液體在病患照護中發揮重要作用，包括水合作用、營養以及藥物和電解質的管理。技術進步，特別是輸液設備的技術進步，以及產業向永續製造和包裝方法的轉變，進一步推動市場擴張。然而，競爭格局並非沒有挑戰，嚴格的監管條件、高昂的製造成本以及新興企業和成熟企業之間的競爭加劇阻礙了成長。儘管存在這些障礙，新的機會出現，特別是隨著對靜脈注射的日益關注以及對個人化醫療策略的需求不斷成長。隨著市場的發展，相關人員需要應對這些複雜的情況，同時利用技術創新和不斷變化的消費者偏好，以增強其在2024-2031靜脈注射液體領域的地位。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• PESTEL分析
• 總體經濟指標
• 供應鏈分析
• 價格分析

靜脈注射液市場規模：依產品分類

• 全靜脈營養
• 周邊靜脈營養

靜脈注射液市場規模：依營養素分類

• 碳水化合物
• 維生素和礦物質
• 單劑量胺基酸
• 非經口脂肪乳劑
• 其他

靜脈注射注射市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東、非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲

競爭資訊

• 前5名企業比較
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 依細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Akshar Pharma
• Fresenius Kabi AG
• MEDEVAC LIFESCIENCES PVT LTD
• Pfizer, Inc.
• LXIR MEDILABS PVT. LTD
• Otsuka Pharmaceutical Co., Ltd.
• Baxter
• B. Braun
• Melsungen AG
• Aishwarya Healthcare
• Vifor Pharma Management Ltd.
• JW Life Science
• Amanta Health Care
• ICU Medical, Inc.
• Grifols SA
• AptarGroup, Inc.
• Sagent Pharmaceuticals, Inc.
• Amgen Inc.
• Novartis AG

結論和建議

Global Intravenous Solutions Market size was valued at USD 11.99 Billion in 2022 and is poised to grow from USD 12.95 Billion in 2023 to USD 23.96 Billion by 2031, growing at a CAGR of 8.0% in the forecast period (2024-2031).

The global intravenous (IV) solutions market is showing robust growth, primarily driven by an increase in chronic disease prevalence, heightened demand for home healthcare services, and a burgeoning elderly population. These sterile liquids serve crucial roles in patient care-providing hydration, nutritional support, and the administration of medications and electrolytes. Technological advancements, particularly in infusion devices, along with an industry shift towards sustainable manufacturing and packaging methods, are further propelling market expansion. However, the landscape is not without challenges; stringent regulatory requirements, high manufacturing expenses, and intensifying competition between emerging and established firms present obstacles to growth. Despite these hurdles, new opportunities are emerging, especially with a heightened focus on nutritional IV solutions and the rising demand for personalized medicine strategies. As the market evolves, stakeholders must navigate these complexities while capitalizing on innovation and shifting consumer preferences to enhance their positioning in the intravenous solutions sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Solutions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intravenous Solutions Market Segmental Analysis

Global Intravenous Solutions Market is segmented by Product, Nutrients, and region. Based on Product, the market is segmented into Total Parenteral Nutrition, Peripheral Parenteral Nutrition. Based on Nutrients, the market is segmented into Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids, Parenteral Lipid Emulsion, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Intravenous Solutions Market

The Global Intravenous Solutions market is experiencing significant growth due to the remarkable rise in home healthcare services. An increasing number of patients are opting for treatments in the comfort of their own homes, particularly those managing chronic conditions, which is driving the demand for home-based IV and infusion therapies. This shift not only enhances patient comfort but also improves treatment adherence, prompting healthcare professionals to expand their offerings of intravenous solutions specifically for home use. As a result, the market is witnessing a surge in demand for adaptable and convenient intravenous therapies that cater to the evolving preferences of patients.

Restraints in the Global Intravenous Solutions Market

The Global Intravenous Solutions market faces significant restraints primarily due to safety concerns and the potential for contamination during the administration or production of IV technologies. These issues can lead to increased regulatory scrutiny and challenges, ultimately hindering the widespread adoption of these solutions and stunting market growth. Furthermore, patients might experience side effects from specific intravenous therapies, which could cause hesitation among healthcare professionals in utilizing such products. This apprehension not only affects the confidence of providers but also contributes to a reluctance in recommending IV treatments, further impacting the overall trajectory of the market.

Market Trends of the Global Intravenous Solutions Market

The Global Intravenous Solutions market is witnessing a significant trend towards home infusion therapy, driven by advancements in portable infusion technologies that enhance patient comfort and outcomes. This shift not only reduces the reliance on hospital admissions but also allows individuals with chronic diseases to receive their treatments in a familiar environment. The integration of telehealth services further supports this trend by enabling healthcare providers to remotely monitor patients, ensuring timely interventions and personalized care. As a result, the market is poised for growth, with increasing demand for innovative intravenous solutions that cater to the evolving needs of patients and healthcare systems.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Supply Chain Analysis
• Pricing Analysis

Global Intravenous Solutions Market Size by Product & CAGR (2024-2031)

• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition

Global Intravenous Solutions Market Size by Nutrients & CAGR (2024-2031)

• Carbohydrates
• Vitamins & Minerals
• Single-dose Amino Acids
• Parenteral Lipid Emulsion
• Others

Global Intravenous Solutions Market Size & CAGR (2024-2031)

• North America, (Product, Nutrients)
  • US
  • Canada
• Europe, (Product, Nutrients)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Nutrients)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Nutrients)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Nutrients)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Akshar Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDEVAC LIFESCIENCES PVT LTD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LXIR MEDILABS PVT. LTD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aishwarya Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vifor Pharma Management Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JW Life Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amanta Health Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sagent Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation